Veronica Bovenzi

1.3k total citations
16 papers, 1.1k citations indexed

About

Veronica Bovenzi is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Veronica Bovenzi has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Veronica Bovenzi's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Epigenetics and DNA Methylation (5 papers) and Cancer-related gene regulation (3 papers). Veronica Bovenzi is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Epigenetics and DNA Methylation (5 papers) and Cancer-related gene regulation (3 papers). Veronica Bovenzi collaborates with scholars based in Canada, France and Italy. Veronica Bovenzi's co-authors include Richard L. Momparler, Moshe Szyf, Nancy Detich, Martin Savard, Jérôme Côté, Fernand Gobeil, Witold Neugebauer, Simon Bélanger, Céléna Dubuc and Louise F. Momparler and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Veronica Bovenzi

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veronica Bovenzi Canada 14 825 216 168 101 81 16 1.1k
Ilaria Visigalli Italy 12 583 0.7× 312 1.4× 100 0.6× 102 1.0× 47 0.6× 17 1.1k
Mark D. Ludman Canada 20 446 0.5× 386 1.8× 107 0.6× 62 0.6× 49 0.6× 41 1.2k
G Bruns United States 17 743 0.9× 220 1.0× 88 0.5× 71 0.7× 47 0.6× 27 1.1k
Antony E. Shrimpton United States 21 842 1.0× 531 2.5× 185 1.1× 108 1.1× 262 3.2× 51 2.0k
Dao Pan United States 16 437 0.5× 300 1.4× 104 0.6× 117 1.2× 21 0.3× 40 871
Frans W. Verheijen Netherlands 25 850 1.0× 300 1.4× 54 0.3× 51 0.5× 38 0.5× 47 1.8k
Sabine Loewer United States 10 1.8k 2.1× 290 1.3× 130 0.8× 151 1.5× 193 2.4× 11 2.3k
Peter M. Kroisel Austria 16 935 1.1× 658 3.0× 109 0.6× 76 0.8× 65 0.8× 38 1.5k
Stavit A. Shalev Israel 29 1.8k 2.2× 709 3.3× 124 0.7× 67 0.7× 64 0.8× 88 2.6k
Sabine Lagger Austria 17 924 1.1× 306 1.4× 46 0.3× 139 1.4× 81 1.0× 23 1.2k

Countries citing papers authored by Veronica Bovenzi

Since Specialization
Citations

This map shows the geographic impact of Veronica Bovenzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Bovenzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Bovenzi more than expected).

Fields of papers citing papers by Veronica Bovenzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica Bovenzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Bovenzi. The network helps show where Veronica Bovenzi may publish in the future.

Co-authorship network of co-authors of Veronica Bovenzi

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica Bovenzi. A scholar is included among the top collaborators of Veronica Bovenzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica Bovenzi. Veronica Bovenzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Dubuc, Céléna, Martin Savard, Veronica Bovenzi, et al.. (2018). Antitumor activity of cell‐penetrant kinin B1 receptor antagonists in human triple‐negative breast cancer cells. Journal of Cellular Physiology. 234(3). 2851–2865. 16 indexed citations
2.
Dubuc, Céléna, Martin Savard, Veronica Bovenzi, et al.. (2018). Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer. Oncotarget. 9(11). 9885–9906. 18 indexed citations
3.
Côté, Jérôme, Veronica Bovenzi, Martin Savard, et al.. (2012). Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model. PLoS ONE. 7(5). e37485–e37485. 42 indexed citations
4.
Côté, Jérôme, Martin Savard, Veronica Bovenzi, et al.. (2010). Selective tumor blood–brain barrier opening with the kinin B2 receptor agonist [Phe8ψ(CH2NH)Arg9]-BK in a F98 glioma rat model: An MRI study. Neuropeptides. 44(2). 177–185. 26 indexed citations
5.
Bovenzi, Veronica, et al.. (2009). Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli. Journal of Cellular Physiology. 222(1). 168–176. 30 indexed citations
6.
Savard, Martin, Simon Bélanger, Werner Müller‐Esterl, et al.. (2008). Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation. Journal of Cellular Physiology. 216(1). 234–244. 53 indexed citations
7.
Côté, Jérôme, Martin Savard, Veronica Bovenzi, et al.. (2008). Novel kinin B1 receptor agonists with improved pharmacological profiles. Peptides. 30(4). 788–795. 26 indexed citations
8.
Bélanger, Simon, Veronica Bovenzi, Jérôme Côté, et al.. (2008). Structure–activity relationships of novel peptide agonists of the human bradykinin B2 receptor. Peptides. 30(4). 777–787. 34 indexed citations
9.
Detich, Nancy, Veronica Bovenzi, & Moshe Szyf. (2003). Valproate Induces Replication-independent Active DNA Demethylation. Journal of Biological Chemistry. 278(30). 27586–27592. 286 indexed citations
10.
Slack, Andrew, Veronica Bovenzi, Pascal Bigey, et al.. (2002). Antisense MBD2 gene therapy inhibits tumorigenesis. The Journal of Gene Medicine. 4(4). 381–389. 44 indexed citations
11.
12.
Momparler, Richard L. & Veronica Bovenzi. (2000). DNA methylation and cancer. Journal of Cellular Physiology. 183(2). 145–154. 322 indexed citations
13.
14.
Bovenzi, Veronica, et al.. (1999). DNA methylation of retinoic acid receptor β in breast cancer and possible therapeutic role of 5-aza-2ʼ-deoxycytidine. Anti-Cancer Drugs. 10(5). 471–476. 67 indexed citations
15.
Eliopoulos, Nicoletta, et al.. (1998). Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice. Gene Therapy. 5(11). 1545–1551. 19 indexed citations
16.
Bovenzi, Veronica, et al.. (1997). Responsiveness of Adenylate Cyclase to Pituitary Gonadotropins and Evidence of a Hormone-Induced Desensitization in the Lizard Ovary. General and Comparative Endocrinology. 107(1). 23–31. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilaria Visigalli Breakdown of academic impact, for papers by Mark D. Ludman Breakdown of academic impact, for papers by G Bruns Breakdown of academic impact, for papers by Antony E. Shrimpton Breakdown of academic impact, for papers by Dao Pan Breakdown of academic impact, for papers by Frans W. Verheijen Breakdown of academic impact, for papers by Sabine Loewer Breakdown of academic impact, for papers by Peter M. Kroisel Breakdown of academic impact, for papers by Stavit A. Shalev Breakdown of academic impact, for papers by Sabine Lagger
Rankless by CCL
2026